Research Papers

25 of 11502 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Multi-modal ultrasound multistage classification of PTC cervical lymph node metastasis via DualSwinThyroid.
Liu Q; Li Y; Hao Y; Fan W; Liu J; Li T; Liu L.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Electrochemotherapy for head and neck cancers: possibilities and limitations.
Morozas A; Malyško-Ptašinskė V; Kulbacka J; Ivaška J; Ivaškienė T; Novickij V.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Machine learning algorithms to uncover risk factors of breast cancer: insights from a large case-control study.
Dianati-Nasab M; Salimifard K; Mohammadi R; Saadatmand S; Fararouei M; Hosseini KS; Jiavid-Sharifi B; Chaussalet T; Dehdar S.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Absence of GATA3/FOXA1 co-expression predicts poor prognosis in upper tract urothelial carcinoma.
Wang Y; Wang Y; He H; Xiong Y.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for…
Fink CA; Buchele C; Baumann L; Liermann J; Hoegen P; Ristau J; Regnery S; Sandrini E; König L; Rippke C; Bonekamp D; Schlemmer HP; Debus J; Koerber SA; Klüter S; Hörner-Rieber J.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
PX-478, an HIF-1α inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer.
Panahi Meymandi AR; Akbari B; Soltantoyeh T; Shahosseini Z; Hosseini M; Hadjati J; Mirzaei HR.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
<sup>18</sup>F-FDG PET/CT imaging in pulmonary sarcomatoid carcinoma.
Luo ZH; Luo XY; Qi WL; Liu Q.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Risk factors for immune-related adverse effects during CPI therapy in patients with head and neck malignancies - a sing…
Jungbauer F; Affolter A; Brochhausen C; Lammert A; Ludwig S; Merx K; Rotter N; Huber L.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A real-world clinicopathological model for predicting pathological complete response to neoadjuvant chemotherapy in bre…
Fang S; Xia W; Zhang H; Ni C; Wu J; Mo Q; Jiang M; Guan D; Yuan H; Chen W.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Bevacizumab increases the sensitivity of olaparib to homologous recombination-proficient ovarian cancer by suppressing …
Iida Y; Yanaihara N; Yoshino Y; Saito M; Saito R; Tabata J; Kawabata A; Takenaka M; Chiba N; Okamoto A.
Front Oncol (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
The future of artificial intelligence in thoracic surgery for non-small cell lung cancer treatment a narrative review.
Abbaker N; Minervini F; Guttadauro A; Solli P; Cioffi U; Scarci M.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Clinical efficacy of plasmid encoding p62/SQSTM1 (Elenagen) in combination with gemcitabine in patients with platinum-r…
Krasny S; Baranau Y; Polyakov S; Zharkova E; Streltsova O; Filimonava A; Siarheyeva V; Kazlouskaya S; Khorau A; Gabai V; Shneider A.
Front Oncol (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Mammography with deep learning for breast cancer detection.
Wang L.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Clinical significance of bone marrow involvement by immunoglobulin gene rearrangement in <i>de novo</i> diffuse large B…
Kim YR; Shin HJ; Yhim HY; Yang DH; Park Y; Lee JH; Lee WS; Do YR; Mun YC; Kim DS; Kim JS.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispe…
Jung S; Schlenk RF; Hackenbruch C; Roldan Pinzon SSL; Bitzer M; Pflügler M; Walz JS; Jung G; Heitmann JS; Salih HR.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Revision surgery for periprosthetic fracture of distal femur after endoprosthetic replacement of knee joint following r…
Jin QL; Su HB; Du SH; Hou CH; Lu M; Dai SW; Lei ZX; Chen W; Li HM.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiv…
Murianni V; Signori A; Buti S; Rebuzzi SE; Bimbatti D; De Giorgi U; Chiellino S; Galli L; Zucali PA; Masini C; Naglieri E; Procopio G; Milella M; Fratino L; Baldessari C; Ricotta R; Mollica V; Sorarù M; Tudini M; Prati V; Malgeri A; Atzori F; Di Napoli M; Caffo O; Spada M; Morelli F; Prati G; Nolè F; Vignani F; Cavo A; Lipari H; Roviello G; Catalano F; Damassi A; Cremante M; Rescigno P; Fornarini G; Banna GL.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A bibliometric analysis of literatures on uterine leiomyosarcoma in the last 20 years.
Huang J; Chen Y; Li Z; Chen M; Huang D; Zhu P; Han X; Zheng Y; Chen X; Yu Z.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Proteomic and metabolomic signatures of rectal tumor discriminate patients with different responses to preoperative rad…
Wojakowska A; Marczak L; Zeman M; Chekan M; Zembala-Nożyńska E; Polanski K; Strugała A; Widlak P; Pietrowska M.
Front Oncol (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation.
Lischalk JW; Akerman M; Repka MC; Sanchez A; Mendez C; Santos VF; Carpenter T; Wise D; Corcoran A; Lepor H; Katz A; Haas JA.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Time to treatment disparities in gastric cancer patients in the United States of America: a comprehensive retrospective…
Sharan S; Bansal S; Manaise HK; Jimenez PB; Raikot SR; Ahmed SH; Popp R; Popp K; Sukniam K; Kowkabany G; Mubarak F; Gabriel E.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Azacitidine induced lung injury: report and contemporary discussion on diagnosis and management.
Alyamany R; Alnughmush A; Almutlaq M; Alyamany M; Alfayez M.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a reg…
Brown LJ; Khou V; Brown C; Alexander M; Jayamanne D; Wei J; Gray L; Chan WY; Smith S; Harden S; Mersiades A; Warburton L; Itchins M; Lee JH; Pavlakis N; Clarke SJ; Boyer M; Nagrial A; Hau E; Pires da Silva I; Kao S; Kong BY.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Appraising the causal association between Crohn's disease and breast cancer: a Mendelian randomization study.
Yu C; Xu J; Xu S; Huang Y; Tang L; Zeng X; Yu T; Chen W; Sun Z.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Advances in statistical methods for cancer surveillance research: an age-period-cohort perspective.
Rosenberg PS; Miranda-Filho A.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared